77 related articles for article (PubMed ID: 11386000)
1. [Type I and IV collagenases and their endogenous regulators in immortalized and transformed fibroblasts].
Solov'eva NI; Vinokurova SV; Dilakian EA; Gureeva TA; Zhurbitskaia VA; Balaevskaia TO
Vopr Med Khim; 2001; 47(1):72-9. PubMed ID: 11386000
[TBL] [Abstract][Full Text] [Related]
2. [Expression of gelatinases A and B and their endogenous regulators in immortal and transformed fibroblasts].
Solov'eva NI; Vinokurova SV; Ryzhakova OS; Gureeva TA; Tsvetkova IV
Biomed Khim; 2009; 55(4):441-50. PubMed ID: 20000122
[TBL] [Abstract][Full Text] [Related]
3. [Expression of interstitial collagenase and its endogenous regulators in immortalized and transformed by E7 gene HPV16 fibroblasts].
Ryzhakova OS; Gureeva TA; Zhurbitskaia VA; Solov'eva NI
Biomed Khim; 2007; 53(3):322-31. PubMed ID: 17722583
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinases (MMP)--MMP-1,-2,-9 and its endogenous activity regulators in transformed by E7 oncogene HPV16 and HPV18 cervical carcinoma cell lines].
Ryzhakova OS; Solov'eva NI
Biomed Khim; 2013; 59(5):530-40. PubMed ID: 24479343
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine A inhibits the expression of membrane type-I matrix metalloproteinase in gingiva.
Chiu HC; Lu YT; Chin YT; Tu HP; Chiang CY; Gau CH; Nieh S; Fu E
J Periodontal Res; 2009 Jun; 44(3):338-47. PubMed ID: 19210333
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Collins HM; Morris TM; Watson SA
Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
[TBL] [Abstract][Full Text] [Related]
7. [Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (review of the own data)].
Solovуeva NI; Timoshenko OS; Gureeva TA; Kugaevskaya EV
Biomed Khim; 2015; 61(6):694-704. PubMed ID: 26716740
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer.
Schmalfeldt B; Prechtel D; Härting K; Späthe K; Rutke S; Konik E; Fridman R; Berger U; Schmitt M; Kuhn W; Lengyel E
Clin Cancer Res; 2001 Aug; 7(8):2396-404. PubMed ID: 11489818
[TBL] [Abstract][Full Text] [Related]
9. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
10. Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of Mycobacterium tuberculosis.
Rivera-Marrero CA; Schuyler W; Roser S; Roman J
Microb Pathog; 2000 Oct; 29(4):231-44. PubMed ID: 10993742
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinases, their inhibitors, and urokinase plasminogen activator in human meningiomas.
Siddique K; Yanamandra N; Gujrati M; Dinh D; Rao JS; Olivero W
Int J Oncol; 2003 Feb; 22(2):289-94. PubMed ID: 12527924
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor induces the gene expression of TIMP-1, -2, and PAI-1: imbalance between the gene expression of MMP-9 and TIMP-1 and -2.
Ottino P; Taheri F; Bazan HE
Exp Eye Res; 2002 Mar; 74(3):393-402. PubMed ID: 12014920
[TBL] [Abstract][Full Text] [Related]
13. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J; Markovic S; Wehland M; Melenhorst WB; van Goor H; Kreutz R
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[TBL] [Abstract][Full Text] [Related]
14. Impact of collagen structure on matrix trafficking by human fibroblasts.
Abraham LC; Vorrasi J; Kaplan DL
J Biomed Mater Res A; 2004 Jul; 70(1):39-48. PubMed ID: 15174107
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 production in human gingival fibroblasts: the role of protein kinase C.
Domeij H; Modéer T; Yucel-Lindberg T
J Periodontal Res; 2004 Oct; 39(5):308-14. PubMed ID: 15324351
[TBL] [Abstract][Full Text] [Related]
16. [Changes in matrix metalloproteinases activities in normal and transformed mouse fibroblasts under effect of antioxidants].
Voronkina IV; Kirpichnikova KM; Smagina LV; Gamaliĭ IA
Tsitologiia; 2008; 50(10):877-81. PubMed ID: 19062520
[TBL] [Abstract][Full Text] [Related]
17. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
[TBL] [Abstract][Full Text] [Related]
18. Actinobacillus actinomycetemcomitans lipopolysaccharide regulates matrix metalloproteinase, tissue inhibitors of matrix metalloproteinase, and plasminogen activator production by human gingival fibroblasts: a potential role in connective tissue destruction.
Bodet C; Andrian E; Tanabe S; Grenier D
J Cell Physiol; 2007 Jul; 212(1):189-94. PubMed ID: 17299802
[TBL] [Abstract][Full Text] [Related]
19. c-jun cooperates with SV40 T-antigen to sustain MMP-2 expression in immortalized cells.
Laderoute KR; Calaoagan JM; Knapp AM; Mendonca HL; Johnson RS
Biochem Biophys Res Commun; 2001 Jun; 284(5):1134-9. PubMed ID: 11414701
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
